Once again, our award-winning, independent editorial team provides thought-provoking insights into the business development decisions and financing deals that shaped the world of pharma, biotech and medtech last year. Download Evaluate Vantage’s 2021 in Review now.
Share:
Once again, our award-winning, independent editorial team provides thought-provoking insights into the business development decisions and financing deals that shaped the world of pharma, biotech and medtech last year.
Download Evaluate Vantage’s 2021 in Review now.
By 2032, the global pharmaceutical market is forecast to reach almost $1.9tn. Inside the innovations, dealmaking, and portfolio strategies transforming the global biopharma pipeline.
